Search filters

List of works by Larry V Rubinstein

A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas

scientific article published on February 3, 2012

A method for utilizing co-primary efficacy outcome measures to screen regimens for activity in two-stage Phase II clinical trials

scientific article published on July 18, 2012

Accelerated Titration Designs for Phase I Clinical Trials in Oncology

scientific article published on 01 August 1997

Clinical Trials in Recurrent Ovarian Cancer

scientific article published on May 1, 2011

Exploratory data analytic techniques to evaluate anticancer agents screened in a cell culture panel

scientific article published on January 1, 1992

Meta-analysis of the Relationship Between Dose and Benefit in Phase I Targeted Agent Trials

scientific article published on November 19, 2012

Modulation of induced resistance to adriamycin in two human breast cancer cell lines with tamoxifen or perhexiline maleate

scientific article published on January 1, 1988

Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)

scientific article published on 13 October 2020

More Randomization in Phase II Trials: Necessary but not Sufficient

scientific article published on June 27, 2011

Neural computing in cancer drug development: predicting mechanism of action

scientific article published on October 16, 1992

Phase I Study of PARP Inhibitor ABT-888 in Combination with Topotecan in Adults with Refractory Solid Tumors and Lymphomas

scientific article published on July 27, 2011

Pilot Study of Interleukin-2 and Lymphokine-Activated Killer Cells Combined With Immunomodulatory Doses of Chemotherapy and Sequenced With Interferon Alfa-2a in Patients With Metastatic Melanoma and Renal Cell Carcinoma

scientific article published on June 17, 1992

Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent

scientific article published on December 1, 2011

Role of independent data-monitoring committees in randomized clinical trials sponsored by the National Cancer Institute

scientific article published on July 1, 1997

Stage II carcinoma of the ovary: An analysis of survival after comprehensive surgical staging and adjuvant therapy

scientific article published on 01 January 1992

Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131)

scientific article published on 10 January 2020